First Amended and Consolidated Complaint in Highland Crusader Offshore Partners LP, of Bermuda; Highland Credit Opportunities CDO Ltd., of the Cayman Islands; Highland Credit Strategies Master Fund LP, of Bermuda; Highland Restoration Capital Partners Master LP, of Delaware, and NexPoint Credit Strategies Fund, of Delaware v. Celtic Pharma Phinco BV, of the Netherlands; Targeted Delivery Technologies Holdings Ltd., of Malta; Targeted Delivery Technologies Ltd., of Malta; Xenova Group Ltd., of England; TDT 044 Ltd., of Bermuda; TDT 054 Ltd., of Bermuda; TDT 077 Ltd., of Bermuda; Celtic Pharmaceutical Holdings LP, of Bermuda; Celtic Pharma Services Bermuda Ltd., of Bermuda; Auven Therapeutics Management LLLP, of the U.S. Virgin Islands, f.k.a. Celtic Therapeutics Management LLLP, as successor-in-interest to Celtic Pharma Management LP; Celtic Pharma Management LP, of Bermuda; Celtic Pharma Management Company Ltd., of Bermuda; Celtic Pharma FIX Ltd., of Bermuda; Celtic Pharma FIX Venture Ltd., of Bermuda; Stephen Evans-Freke, of Ireland and the United Kingdom, and John Mayo, of England, at the Supreme Court of the State of New York, County of New York.
Topics
Bermuda Cayman Islands Fraud Investment IrelandKeywords
Auven Therapeutics Management LLLP Celtic Pharma FIX Ltd. Celtic Pharma FIX Venture Ltd. Celtic Pharma Management Company Ltd. Celtic Pharma Management LP